Our findings demonstrate the therapeutic utility of GSTO1 inhibitors as anticancer agents and identify the novel cellular pathways under GSTO1 regulation in colorectal cancer
It's also important to note that these medications carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
MT1 has potential anxiety benefits
New findings may emerge which may contradict or confirm the information provided in this article
Low glutathione levels can lead to dangerous conditions and irritating symptoms, and low levels are also associated with worsening symptoms from serious diseases such as cystic fibrosis, AIDS, HIV, macular degeneration, Parkinsons disease, COPD, Alzheimers, other neurodegenerative disorders, and things as common as aging